The USPSTF grade D recommendation against the screening of prostate cancer released in 2012 has led to major debates on how PSA screening should and should not be done, how to better diagnose prostate cancer, and determine which diagnosed cancers should be left untreated.25–27. Here, KLK3 is linked to prostate carcinoma.